Vol. 276, Issue 3, H953-H960, March 1999
Modulation of AV nodal and Hisian conduction by changes in
extracellular space
Keith G.
Lurie1,
Atsushi
Sugiyama2,
Scott
McKnite1,
Paul
Coffeen1,
Keitaro
Hashimoto2, and
Shigeru
Motomura3
1 Cardiac Arrhythmia Center,
University of Minnesota, Minneapolis, Minnesota
55455; 2 Department of
Pharmacology, Yamanashi Medical Center, 409-38 Yamanashi;
and 3 Department of
Pharmacology, Hirosaki Medical Center, 036 Hirosaki, Japan
 |
ABSTRACT |
Previous studies have demonstrated that the
extracellular space (ECS) component of the atrioventricular (AV) node
and His bundle region is larger than the ECS in adjacent contractile
myocardium. The potential physiological significance of this
observation was examined in a canine blood-perfused AV nodal
preparation. Mannitol, an ECS osmotic expander, was infused directly
into either the AV node or His bundle region. This resulted in a
significant dose-dependent increase in the AV nodal or His-ventricular
conduction time and in the AV nodal effective refractory period.
Mannitol infusion eventually resulted in Wenckebach block
(n = 6), which reversed with mannitol
washout. The ratio of AV nodal to left ventricular ECS in tissue frozen
immediately on the development of heart block (n = 8) was significantly higher in
the region of block (4.53 ± 0.61) compared with that in control
preparations (2.23 ± 0.35, n = 6, P < 0.01) and donor dog hearts (2.45 ± 0.18, n = 11, P < 0.01) not exposed to mannitol.
With lower mannitol rates (10% of total blood flow), AV nodal
conduction times increased by 5-10% and the AV node became
supersensitive to adenosine, acetylcholine, and carbachol, but not to
norepinephrine. We conclude that mannitol-induced changes in AV node
and His bundle ECS markedly alter conduction system electrophysiology
and the sensitivity of conductive tissues to purinergic and cholinergic agonists.
heart; cardiac conduction system; osmolality; adenosine; acetylcholine; heart block; mannitol; atrioventricular
 |
INTRODUCTION |
ALTHOUGH THE ELECTROPHYSIOLOGY of the atrioventricular
(AV) node and His bundle region of the heart has been studied
extensively over the past several decades, much less is known about the
unique biochemical features of this amalgam of modified cardiac muscle and nerve cells (9-11, 16, 19). Hampered previously
by complex anatomy, cellular heterogeniety, and microscopic size, over
the past several years, new microanalytic tools have been developed to
study anatomically complex regions of the heart, including the AV nodal
region. We used these techniques to measure regional differences in
extracellular space between conductive and adjacent contractile tissues
(10). In studies in rat and rabbit hearts, we observed that the
extracellular space component of the AV nodal region was 2.5 times
larger than the extracellular space component in the adjacent
contractile tissue. On the basis of wet-to-dry weight tissue ratios and
the serum concentration of extracellular markers, we estimated that
~30% of the contractile myocardium and 70% of the AV nodal region
of the beating heart was composed of extracellular space (10).
Given the existence of such marked regional differences in
extracellular space, we have speculated that changes in extracellular space induced by endogenous processes such as ischemia and
aging or exogenous hyperosmotic agents such as mannitol would alter AV
nodal conduction characteristics (10). In the present study, we tested
this hypothesis in a well-established blood-perfused canine AV nodal
preparation (7, 8, 14, 15, 18). The canine blood-perfused AV nodal
preparation provides an opportunity to study electrophysiological,
biochemical, and anatomic differences between different regions of the
heart in a single preparation. With this physiological preparation,
perfusion can be selectively directed to either the AV node or the His
bundle region, and we evaluated the electrophysiological and
biochemical effects of mannitol. When injected into the coronary
circulation of the preparation, this osmotically active agent moves
passively from the vasculature into the interstitium but does not move
intracellularly. The results support the hypothesis that alterations in
extracellular space in the AV nodal region dramatically alter the
electrical properties of this region.
 |
METHODS |
Blood-Perfused Canine Preparation
All experiments were performed according to the guidelines of the
Committee for Animal Experimentation at the University of Minnesota.
The canine blood-perfused AV nodal preparation has been well described
previously (7, 8, 15, 18). In brief, the coronary arteries were
cannulated in an explanted canine heart, which we will refer to as the
"preparation" heart. Only vessels that supply blood to the sinus
node, AV node, His bundle, and interventricular septum remained patent;
all others were ligated. Atrial and ventricular muscle subserved by the
ligated coronary arteries was removed. The preparation was trimmed such
that the sinus node and AV nodal region were visualized. Endocardial
electrodes were gently attached to the region adjacent to the sinus
node, His bundle, and right ventricular septal region. Bipolar
electrograms were recorded continuously. The preparation was paced as
needed. This preparation received oxygenated blood from a "donor"
dog, which was previously anesthetized and treated with heparin as also
previously described (15). The temperature of the preparation was
maintained at 37.0 ± 0.5°C. Perfusion pressure was maintained at 120 mmHg. The preparation time varied between 45 min and 1.5 h.
After reperfusion, the preparations typically fibrillated for ~30-45 min, at which point in time normal sinus rhythm was
restored. After sinus rhythm was restored in these preparations, the
preparation heart remained constant, from an electrophysiological
standpoint (8, 14, 15), for >4 h.
The coronary anatomy of the dog is unlike that of some other species in
that the first septal perforator artery, a branch of the left anterior
descending coronary artery, provides most of the blood to the
His-Purkinje system. Similarly, the circumflex coronary artery provides
most of the blood supply to the AV nodal region. Blood flow was
measured in each coronary artery using electromagnetic flow probes
(Howell Instruments, Camarillo, CA) attached to the perfusion cannula.
This enabled instantaneous measurement of flow in each of the three
coronary arteries throughout the experiments as previously described
(14, 15). With this model, injections of mannitol and other
cardioactive agents were directed selectively into one particular
region of the conduction system.
Mannitol was prepared as a 20% (wt/vol) solution of either normal
saline or Tyrode solution, depending on the experiment. It was infused
at different rates of the total coronary blood flow (10-50%) into
either the circumflex or first septal coronary artery.
Effects of Mannitol on AV Nodal and Hisian Conduction and
Extracellular Space
Electrophysiology studies.
Once preparations had returned to a normal sinus rhythm, pacing was
performed at a cycle length of 400 ms with a pulse width of 0.5 ms and
an amplitude of 1.0 V delivered via a quadrapolar electrode attached to
the right atrial tissue near the sinus node. The atrio-Hisian (AH),
Hisian-ventricular (HV), and R-R intervals were recorded continuously
as previously described (14). Under basal conditions, the Wenckebach
block cycle length and the effective refractory period (ERP) at a
pacing cycle length of 400 ms were determined. The responsivity to
acetylcholine was also evaluated in each preparation as previously
described (14). After the baseline electrical characteristics of the
preparation were obtained, mannitol (20% wt/vol) was infused at
varying percentages (10-50%) of the total blood flow, depending
on the specific experimental protocol. In studies designed to examine
the potential to induce Wenckebach block with infusions of mannitol,
the mannitol infusions were initiated at 10% of the total blood flow
to a specific coronary artery. The infusion rate was adjusted every
10-15 s, depending on the overall blood flow to the target
coronary artery. After 5 min, the infusion rate was increased
sequentially every 5 min to 20, 25, 30, 40, and 50% of the total
coronary artery blood flow until Wenckebach block was observed. The ERP
was determined at the different infusion rates of mannitol until block
occurred. When heart block was induced, the mannitol infusion was
immediately turned off.
In studies designed to examine the sensitivity of the AV node to
purinergic, cholinergic, and adrenergic agents before and after
mannitol, mannitol was infused into the circumflex artery as described
above at 10% of the total blood flow. After 5 min, once the AV nodal
conduction time stabilized, a dose-response curve to either adenosine,
carbachol, or norepinephrine was obtained. There was a minimum of 3 min
between each drug infusion. When the same preparation was used for more
than one agonist, we waited 10 min before using a second agonist.
Biochemical studies.
In preparations in which extracellular space was measured, 200 mg/kg of
inulin (1 g/10 ml normal saline solution at 37°C) was infused into
the jugular vein of the donor dog 15 min before initiation of the
mannitol infusion. Blood samples were obtained every 3 min from the
arterial blood perfusing the preparation heart to evaluate inulin
concentrations over time as previously described (10). Inulin levels,
measured in the serum from the donor dog, achieved a stable equilibrium
between 10 and 15 min after venous infusion into the donor dog. In
these control heart preparations, no mannitol was administered. In
controls, 20 min after inulin was injected into the donor dogs, the AV
node and His bundle region were rapidly excised and plunged into
tetrafluoroethane (Stephens Scientific, Riverdale, NJ) previously
cooled to
80°C in liquid nitrogen. In experiments in which
mannitol was administered, the preparations were rapidly removed just
at the time that heart block was observed electrophysiologically, and
these preparations were rapidly frozen as described above. The frozen
preparations were stored at
40°C until biochemical
measurements were performed.
Inulin was measured in serum and tissue as previously described (10).
Tissue inulin was assayed in portions of the right atrium, AV node, His
bundle, and left ventricle in freeze-dried microdissected sections. The
discrete regions of the conduction system were localized by using both
anatomic landmarks and a stain for acetylcholinesterase activity as
previously described (5, 10, 19, 21).
Biochemicals were obtained from Sigma Chemical (St. Louis, MO), and
enzymes used for the enzymatic measurement of inulin were obtained from
Boehringer Mannheim (Indianapolis, IN). Animals were obtained from
class B breeders through Laboratory Animal Medicine at the University
of Minnesota. Mongrel dogs (10-25 kg) of either gender were used
in these studies.
Statistical Analysis
Data were recorded and analyzed as previously described (7, 14). All
data were expressed as means ± SE. Statistical significance within
a parameter was evaluated by one-way repeated-measures ANOVA. When a
P value was <0.05 by ANOVA, the
intervention was judged as having affected the parameter. In this case,
the statistical significance between the control and a value at a
particular time point after the intervention (for example, mannitol
infusion) was determined by contrasts for mean values comparison, and a P value <0.05 was considered
significant. The statistical significance between groups was evaluated
by one-way factorial ANOVA followed by multiple-comparison tests with
Bonferroni-Dunn. A P value of <0.05
was considered statistically significant.
 |
RESULTS |
Electrophysiology Studies
The effects of mannitol on the ERP and AV nodal conduction times from
six preparations are shown in Table 1. The
mean AV conduction time for the six preparations before mannitol
infusion was 148 ± 4.2 ms, and the mean AH time was 112.2 ± 3.6 ms. These values are similar to those we have previously reported (14, 15). With incremental increases in the infusion rate of mannitol, both
the refractoriness of the AV node and the AH interval increased in
parallel. The differences in the ERP with increasing concentrations of
mannitol were statistically significant. There were fewer data points
with the higher mannitol infusion rates, because AV block was observed
in 50% of the preparations with 30% mannitol infusion rates.
A representative tracing of the AV conduction time from a single
preparation during the administration of mannitol is shown in Fig.
1. The right atrium was paced at a cycle
length of 400 ms. After infusion of mannitol at 10% of the baseline
blood flow, AV nodal conduction time began to increase. As the
conduction time continued to be prolonged, there was the appearance of
two regular but distinct AV conduction time intervals (Fig. 1, arrow) just before the onset of Wenckebach block. At that point, the mannitol
infusion was turned off and AV nodal conduction was restored. Although
1:1 AV conduction was rapidly restored with mannitol washout, the time
required for AV nodal conduction times to return to premannitol values
varied. However, this kind of heart block was reproducible from one
preparation to the next and was reproducible within the same
preparation. The median amount of mannitol solution (2 g/10 ml normal
saline or Tyrode solution) needed to generate heart block was 25%
(range 10-50%) of the coronary artery blood flow. Full
reversibility of the mannitol effect was dependent on the number of
times the preparation was exposed to mannitol and the overall quality
of the preparation at the time of the initial mannitol infusion.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Representative tracing of atrio-Hisian conduction time from a single
canine blood-perfused atrioventricular (AV) nodal preparation. After
initiation of an infusion of a mannitol solution (20% wt/vol of Tyrode
solution) at 10% of baseline blood flow to AV node, AV nodal
conduction time began to increase. As conduction time increased, two
distinct AV conduction time intervals (arrow) appeared just before
onset of Wenckebach block. At that point, mannitol infusion was turned
off and 1:1 AV nodal conduction promptly returned.
|
|
Results from a representative experiment demonstrating the relationship
between AV nodal refractoriness and mannitol infusion rates (Fig.
2) highlight the effects of mannitol in
these preparations. With an increase in the infusion of mannitol from 0 to 30% of the total blood flow to the circumflex coronary artery, the
relationship between
A1A2
and
A2H2
in Fig. 2 shifted upward and to the right in a reproducible and
characteristic fashion. This shift in the AV nodal
decremental conduction curves demonstrates that mannitol infusion
results in a dose-dependent prolongation of the refractoriness of the
AV node. A1 is the atrial pacing cycle length (400 ms), and
A2 is the premature atrial stimulus.
A1A2 is the coupling interval between
A1 and A2. A2H1 is the
recorded atrio-His interval following the delivered premature atrial
impulse (A2).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 2.
Representative experiment demonstrates relationship between AV nodal
refractoriness and mannitol infusion rates. With increase in infusion
of mannitol from 0 to 30% of total blood flow in circumflex coronary
artery, which supplies blood to AV node, relationship between
A1A2
and
A2H2
shifted upward and rightward in a consistent and characteristic
fashion. A1 is the atrial pacing cycle length (400 ms), and
A2 is the premature atrial stimulus.
A1A2 is the coupling interval between
A1 and A2. A2H1 is the
recorded atrio-His interval following the delivered premature atrial
impulse (A2).
|
|
Infusion of mannitol selectively into either the AV nodal or first
septal artery reproducibly resulted in either reversible AV nodal block
or reversible infra-Hisian block. When mannitol was infused into the
first anterior septal artery of the left anterior descending coronary
artery selectively to the His bundle region, infra-Hisian block could
be selectively induced without changing the AV nodal conduction
properties (Table 2). Figure 3 is an example of electrograms from a
typical experiment in which infra-Hisian block was induced with
mannitol and then readily reversed as the mannitol was washed out.
Invariably, 1:1 conduction was restored within <2 min after the
mannitol infusion was terminated.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Infusion of mannitol selectively into first septal artery reproducibly
resulted in reversible infra-Hisian block. Electrograms were recorded
from endocardial electrodes in a representative experiment.
A: baseline recordings. A, atrial; H,
His; V, ventricle; HV, His-ventricular interval (40 ms).
B: induction of infra-Hisian block
with an infusion of mannitol. C:
infra-Hisian block readily reversed with termination of mannitol
infusion.
|
|
Biochemical Measurements
Measurements of extracellular space were performed in both the
preparation hearts as well as in hearts from the donor dogs. For these
experiments, inulin was infused into the donor dog, and, after serum
inulin levels had reached an equilibrium (20 min after the inulin
infusion), hearts were rapidly removed and tissue inulin was measured
as the extracellular space marker. The results demonstrated in Table
3 are similar to findings we have
previously observed in both rat and rabbit hearts (5, 10).
Serum inulin levels were similar in the control and mannitol-treated preparations. As shown in Table 3 and Fig.
4, the extracellular space ratio between
the AV node and left ventricle increased significantly with the
mannitol infusions. The AV node-to-left ventricular extracellular space
ratio was 2.45 ± 0.18 from the control donor hearts
(n = 11) and 2.23 ± 0.35 from the
control preparation hearts (n = 6). Similar conductive-to-contractile tissue ratios were observed from the
measurement of inulin from the His bundle region and right atrium.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Measurement of extracellular space in donor hearts, control
preparations, and preparations after infusion of mannitol demonstrated
that the ratio of AV node to contractile muscle was ~2.2:1.0 under
control conditions. From infusion of preparation with mannitol (2 g/10
ml normal saline solution) until development of Wenckebach block (at
which point the preparations were immediately frozen), the ratio of AV
node to left ventricular (LV) extracellular space increased markedly.
The increase in this ratio in mannitol-treated preparations
(n = 8) was significantly higher than
in donor (n = 11) and preparation
(n = 6) controls. RA, right atrium.
|
|
Table 3 and Fig. 4 also demonstrate the changes observed in the
extracellular space of conductive and contractile tissues from
preparations (n = 8) infused with
mannitol (2 g/10 ml normal saline solution) until the development of
Wenckebach block. These data reflect the extracellular space
measurements at the time of heart block. In the mannitol-infused
preparations, the AV node-to-left ventricular extracellular space ratio
was markedly increased after the mannitol treatment. The ratio between
AV nodal and left ventricular extracellular space increased from 2.23 ± 0.35 in control preparations to 4.53 ± 0.61 in
mannitol-treated preparations (P < 0.001) and was associated with electrophysiological evidence of heart block.
Mannitol-Induced Supersensitivity to Adenosine and Acetylcholine
We next examined the relationship between the responsivity of the AV
node to cholinergic, purinergic, and adrenergic agonists before and
after mannitol infusion. In these studies, mannitol was infused at 10%
of baseline blood flow. As shown in Fig. 5, mannitol infusion resulted in a significant increase in the sensitivity of the AV node to the negative dromotropic properties of acetylcholine, adenosine, and carbachol. The adenosine and carbachol
concentration curves were shifted to the left when preparations were
treated with an infusion of mannitol (2 g/10 ml Tyrode solution) at an infusion rate of 10% of the total coronary flow. In these studies the
AV nodal tissue was significantly more sensitive to lower concentrations of adenosine and carbachol when injected into the AV
nodal artery during infusion of mannitol when compared with injection
of Tyrode solution alone. Evaluation of the effective dose of agonist
resulting in a 20-ms increase in the AV conduction time
(ED20) revealed that mannitol
decreased ED20 from >300 to 100 µg with adenosine, from 0.35 to 0.17 µg with carbachol, and from
0.31 to 0.24 µg with acetylcholine (Fig. 5). In contrast, there was
no change in sensitivity of the AV node to the adrenergic agonist
norepinephrine. The AH interval decreased in a characteristic fashion
when norepinephrine (3-30 µg) was injected in the absence or
presence of a concurrent infusion of mannitol at 10% of the total
blood flow.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 5.
Mannitol infusion at 10% of total blood flow to AV nodal region
resulted in a marked increase in sensitivity of AV node to negative
dromotropic properties of ACh (n = 4 experiments), adenosine (n = 4), and
carbachol (n = 2), with no change in
sensitivity of preparation to norepinephrine (NE;
n = 4). Adenosine, ACh, and carbachol
dose-response curves were shifted upward and leftward when preparations
were treated with an infusion of mannitol (2 g/10 ml Tyrode solution)
at an infusion rate of 10% of total coronary blood flow. Tyrode
solution infusion alone had no significant effect on AH interval.
* P < 0.05 compared with
control values and preparations exposed to Tyrode solution alone. AVB,
AV block; ratios in parentheses are proportion of preparations that
developed heart block at a given agonist concentration.
|
|
 |
DISCUSSION |
The relationship between structure and function is vital to
understanding the mechanism of impulse transduction through the AV
nodal region of the heart. Results from the present study performed in
dog hearts confirmed our previous observations made in rat and rabbit
hearts that the extracellular space component of the AV nodal region is
~2.5 times larger than the corresponding extracellular space in
adjacent contractile muscle (5, 10). The current results also
demonstrated two new basic physiological observations. The first is
that infusion of mannitol selectively into the AV nodal artery resulted
in a prolongation of both the AV nodal conduction time and ERP and
eventually resulted in the development of reversible heart block.
Similar findings were observed with selective infusion of mannitol into
the His bundle region. Measurement of the extracellular space component
of the AV node at the time of block demonstrated that heart block in
these preparations was associated with a significant increase in the
extracellular space component of the AV node compared with that of
control preparations. These observations suggest that modulation of the
extracellular space component of the AV node is associated with
alterations in AV nodal conduction velocity, AV nodal refractoriness,
and the development of reversible heart block.
The second new observation from these studies is that infusion of
concentrations of mannitol sufficient to slow AV nodal conduction but
not create AV block resulted in a marked supersensitivity of the AV
nodal region to cholinergic and purinergic agonists. These findings
support the hypothesis that the sensitivity of the AV nodal region to
selective agonists may be enhanced by small shifts in extracellular
space. The mechanism underlying the increased sensitivity to
cholinergic and adenosinergic agonist remains speculative. Mannitol may
alter ion channel activity such as the chloride swell channel (4)
and/or potassium channel (17, 22), gap junction integrity,
changes in repolarization, or receptor-G protein-receptor coupling, or
it may induce stretch or alter the metabolism of agonists or secondary
messengers secondary to the increase in the interstitial space (1). The
generation of de novo heart block in the clinical setting may be
secondary in some cases to selective increases and/or
alterations in the AV nodal and/or Hisian extracellular space,
perhaps indirectly as a result of increased sensitivity to endogenous
negative dromotropic neurotransmitters such as acetylcholine and
adenosine. In the present study, selective infusion of the AV nodal
artery with a mannitol-containing solution resulted in selective AV
nodal block with maintenance of intact His-Purkinje conduction.
Similarly, infusion of the same mannitol solution selectively into the
His bundle via the first septal perforator artery resulted in selective
infra-Hisian block with maintenance of intact AV nodal conduction.
These results demonstrate that the interstitium surrounding the AV
nodal cells and the His bundle region are anatomically distinct spaces.
Moreover, processes that selectively alter the extracellular space
within each respective region can induce regionally specific heart
block. Heart block within each of these distinct regions could be
rapidly induced and was rapidly reversible on washout of the mannitol solution.
Taken together, these results suggest that modulation of extracellular
space within the cardiac conduction system is a tightly regulated
process. At present, little is known about the basic physiological
regulatory processes governing extracellular space in the conduction
system (23). We hypothesize that agents or processes that result in an
increase in extracellular space, such as infusions of hyperosmolar
agents, ischemia, and probably aging, will result in an
increased propensity for heart block. For example, in patients with
inferior myocardial infarctions, who often develop reversible AV nodal
block, an increased extracellular space within the AV nodal region
secondary to ischemia may result in an increased sensitivity of
that region to both adenosine and acetylcholine (4, 6). A similar
effect of hyperosmolar agents has been previously observed in the
atria, where infusion of mannitol and hypertonic saline resulted in the
development of atrial fibrillation and increased sensitivity to
purinergic and cholinergic agents (3). In view of the present
observations, we believe that the regulation of AV nodal conduction,
even in the absence of ischemia, may be in part modulated by
subtle changes in extracellular space.
Whereas induction of AV nodal heart block with mannitol infusion is
associated with an increase in the extracellular space component of the
AV node, this correlation may be by association and not causal. In
these studies we were unable to examine potential changes in the
intracellular volume of AV nodal cells under control conditions and
after mannitol. Thus it is possible that rapid cell shrinkage, rather
than, or in addition to, extracellular space expansion, was involved in
the development of AV nodal block in these experiments. In addition, it
is possible that endogenous adenosine was not metabolized as rapidly in
the presence of mannitol or an increased extracellular space and that
the observed AV block was a consequence of altered adenosine
metabolism. These questions remain under investigation. Another
potential limitation of these observations is that we tested only one
osmotically active agent, mannitol, in the current studies. However, we
have created reversible heart block with both mannitol and sorbitol
infusions using a rat heart Langendorff preparation (unpublished
observations), and similar kinds of reversible conduction system block
have been reported in patients who received hyperosmotic contrast
agents during cardiac catheterization procedures (23). Thus it is
likely that the results in the current study are due not to a unique property of mannitol but rather to the osmotic effects of this agent.
Finally, the animal model itself could be criticized. For example, a
potential limitation of the present studies relates to changes in the
regulation of extracellular space in the AV nodal preparation itself.
The present results, demonstrating that the AV node-to-left ventricular
extracellular space ratio is ~2.5, are identical to results we have
produced previously in rat and rabbit hearts frozen immediately after
they were removed from the chest, in the absence of subsequent blood
perfusion as in the present experiments (10). In addition, similar
results were observed in studies in the control donor dog hearts and in
the canine blood-perfused AV nodal preparations in the present
experiments, demonstrating that the processes that control
extracellular space appear to remain intact in the blood-perfused AV
nodal preparations. Although no model is perfect, we chose the
blood-perfused canine model because of the stability of the preparation
and because we could infuse drugs directly and selectively into each of
the respective coronary arteries (7, 14, 15). This is one of the only
ex vivo models in which one can selectively infuse drug into either the
AV node or the His bundle region.
In other parts of the body, for example, the brain and spinal cord,
alterations in extracellular space can result in dramatic functional
abnormalities. Changes in the extracellular space in the hippocampus
can result in seizure activity (1, 2, 12, 20). This activity is tightly
linked to cellular osmolality, and restoration of the extracellular
space component to control values results in cessation of seizure
activity. We speculate that similar processes may help to regulate
impulse conduction velocity within different regions of the cardiac
conduction system and, perhaps, throughout the contractile myocardium.
Disorders of cardiac conduction may result, in part, from disorders in
extracellular space regulation. The processes that modulate
extracellular-intracellular fluid balance remain poorly understood yet
vital to the normal physiology of the heart (11). In pathological
states, and with cell dropout associated with aging in particular, the
importance of extracellular space homeostasis may be more important
than previously recognized. The present experiments serve to underscore the potential critical role that the regulation of extracellular space
plays in the beat-to-beat impulse transduction in the heart. A better
understanding of these processes may lead to pharmacological therapies
for certain types of cardiac arrhythmias.
 |
ACKNOWLEDGEMENTS |
We thank Barry Detloff for excellent technical assistance.
 |
FOOTNOTES |
Address for reprint requests: K. G. Lurie, Cardiac Arrhythmia Center,
Box 508 U.M.H.C., Univ. of Minnesota, 420 Delaware St. SE, Minneapolis,
MN 55455 (E-mail: lurie002{at}maroon.tc.umn.edu).
Received 12 June 1997; accepted in final form 3 December 1998.
 |
REFERENCES |
1.
Aukland, K.,
and
G. Nicolaysen.
Interstitial fluid volume: local regulatory mechanisms.
Physiol. Rev.
61:
556-643,
1981[Free Full Text].
2.
Ballyk, B.,
S. Quackenbush,
and
R. Andrew.
Osmotic effects on the CA1 neuronal population in hippocampal slices with special reference to glucose.
J. Neurophysiol.
65:
1055-1066,
1991[Abstract/Free Full Text].
3.
Chiba, S.,
Y. Suzuki,
and
K. Hashimoto.
Atrial fibrillation induced by infusion of hypertonic solutions into the canine sinus node artery in situ.
J. Pharmacol. Exp. Ther.
167:
274-281,
1969[Abstract/Free Full Text].
4.
Duan, D.,
B. Fermini,
and
S. Nattel.
Alpha-adrenergic control of volume-regulated Cl
currents in rabbit atrial myocytes: characterization of a novel ionic regulatory mechanism.
Circ. Res.
77:
379-393,
1995[Abstract/Free Full Text].
5.
El-Badawi, A.,
and
E. A. Schenk.
Histochemical methods for separate, consecutive and simultaneous demonstration of acetylcholinesterase and norepinephrine in cryostat sections.
J. Histochem. Cytochem.
15:
580-588,
1967[Abstract].
6.
Harvey, R. D.,
and
J. R. Hume.
Autonomic regulation of a chloride current in heart.
Science
244:
983-985,
1989[Abstract/Free Full Text].
7.
Hashimoto, K.,
and
K. Hashimoto.
Direct perfusion of the canine ventricular septum via the anterior septal artery.
Tohoku J. Exp. Med.
105:
99-100,
1971[Medline].
8.
Hashimoto, K.,
T. Iijima,
K. Hashimoto,
and
N. Taira.
The isolated and cross-circulated AV node preparation of the dog.
Tohoku J. Exp. Med.
107:
263-275,
1972[Medline].
9.
Kusumoto, F. M.,
K. G. Lurie,
J. Dutton,
H. Capili,
and
J. B. Schwartz.
Effects of aging on AV nodal and ventricular
-adrenergic receptors in the Fisher 344 rat.
Am. J. Physiol.
266 (Heart Circ. Physiol. 35):
H1408-H1415,
1994[Abstract/Free Full Text].
10.
Lurie, K. G.,
J. Dutton,
and
P. Wiegn.
Regional distribution of ECS in contractile and conductive elements of rat and rabbit heart.
Am. J. Physiol.
263 (Heart Circ. Physiol. 32):
H168-H176,
1992[Abstract/Free Full Text].
11.
Lurie, K.,
A. Loy,
J. Dutton,
and
F. Matschinsky.
Measurement of extracellular space in the rabbit AV node.
J. Histochem. Cytochem.
39:
1671-1677,
1991[Abstract].
12.
McBain, C.,
S. Traynelis,
and
R. Dingledine.
Regional variation of extracellular space in the hippocampus.
Science
249:
674-677,
1990[Abstract/Free Full Text].
13.
Molenaar, P.,
J. J. Smolich,
F. D. Russell,
L. R. McMartin,
and
R. J. Summers.
Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (
)-isoproterenol infusion.
J. Pharmacol. Exp. Ther.
255:
393-400,
1990[Abstract/Free Full Text].
14.
Motomura, S.,
and
K. Hashimoto.
2-Adrenoreceptor-mediated positive dromotropic effects on atrioventricular node of dogs.
Am. J. Physiol.
262 (Heart Circ. Physiol. 31):
H123-H129,
1992[Abstract/Free Full Text].
15.
Motomura, S.,
T. Iijima,
N. Taira,
and
K. Hashimoto.
Effects of neurotransmitters injected into the posterior and anterior septal artery on the automaticity of the atrioventricular junction area of the dog heart.
Circ. Res.
37:
146-155,
1975[Abstract/Free Full Text].
16.
Saito, K.,
A. Kuroda,
and
H. Tanaka.
Characterisation of
1 and
2 adrenoceptor subtypes in the atrioventricular node of diabetic rat hearts by quantitative autoradiography.
Cardiovasc. Res.
25:
950-954,
1991[Medline].
17.
Strasberg, B.,
R. Bassevich,
A. Mager,
J. Kusniec,
A. Sagie,
and
S. Sclarovsky.
Effects of aminophylline on atrioventricular conduction in patients with late atrioventricular block during inferior wall acute myocardial infarction.
Am. J. Cardiol.
67:
527-528,
1991[Medline].
18.
Sugiyama, A.,
M. Kobayashi,
G. Tsujimoto,
S. Motomura,
and
K. Hashimoto.
The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations.
Jpn. J. Pharmacol.
50:
421-427,
1989[Medline].
19.
Sugiyama, A.,
S. McKnite,
P. Wiegn,
and
K. G. Lurie.
Measurement of cAMP in the cardiac conduction system of rats.
J. Histochem. Cytochem.
43:
601-605,
1995[Abstract].
20.
Svoboda, J.,
and
E. Sykova.
Extracellular space volume change in the rat spinal cord produced by nerve stimulation and peripheral injury.
Brain Res.
560:
216-224,
1991[Medline].
21.
Tripathi, O.,
and
A. Bhatnagar.
Extracellular fluid space in rabbit SA node and atria as studied with 14C-inulin and 14C-sucrose.
Jpn. J. Pharmacol.
37:
1057-1060,
1987.
22.
Wesley, R. C., Jr.,
B. B. Lerman,
J. P. DiMarco,
R. M. Berne,
and
L. Belardinelli.
Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine.
J. Am. Coll. Cardiol.
8:
1232-1234,
1986[Abstract].
23.
White, C. W.,
D. L. Eckberg,
T. Inasaka,
and
F. M. Abboud.
Effects of angiographic contrast media on sino-atrial nodal function.
Cardiovasc. Res.
10:
214-223,
1976[Medline].
Am J Physiol Heart Circ Physiol 276(3):H953-H960
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society